Exploring Biosimilar Reference Antibodies(Page)
Exploring Biosimilar Reference Antibodies for Advanced Research and Biotech Applications
Sargramostim (rhu GM-CSF) and Immune Checkpoint Inhibitors : Combinatorial Therapeutic Studies in Metastatic Melanoma(Post)Metastatic melanoma presents significant treatment challenges, but advancements in immunotherapy, particularly the combination of Sargramostim (rhu GM-CSF) and immune checkpoint inhibitors, offer pro
Product results
Product results
- Product
- Qty in Cart
- Quantity
- Price
- Subtotal
-
€442.00 -
SHIKARI Q-PEM (Pembrolizumab) ELISA | 30137260
€1,981.20SHIKARI Q-PEM (Pembrolizumab) ELISA | 30137260 | IBL International Application: ELISA Category Type: Immunology181-30137260€1,981.20 -
SHIKARI S-ATP (Anti-Pembrolizumab Ab) ELISA | 30137262
€1,981.20SHIKARI S-ATP (Anti-Pembrolizumab Ab) ELISA | 30137262 | IBL International Application: ELISA Category Type: Immunology181-30137262€1,981.20 -
pHR_Gal4UAS_Pembrolizumab_heavychain_T2A_ Pembrolizumab_lightcha
€345.80Order pHR_Gal4UAS_Pembrolizumab_heavychain_T2A_ Pembrolizumab_lightcha from Nova Lifetech / Life Science Market by email to eu@genprice.comPVT11019€345.80